Cytomegalovirus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

CMV Immunity Monitoring in Lung Transplant Recipients
Condition:   Lung Transplant; Complications Interventions:   Device: Cytomegalovirus T Cell Immunity Panel (CMV-TCIP);   Diagnostic Test: Donor-Derived Cell-Free DNA (dd-cfDNA) Assay;   Drug: Valganciclovir Sponsors:   NYU Langone Health;   Viracor Eurofins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2023 Category: Research Source Type: clinical trials

Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients
Condition:   Kidney Transplant Infection Intervention:   Drug: ROVALCYTE Sponsor:   University Hospital, Rouen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2023 Category: Research Source Type: clinical trials

CMV Immunity Monitoring in Lung Transplant Recipients
Condition:   Lung Transplant; Complications Interventions:   Device: Cytomegalovirus T Cell Immunity Panel (CMV-TCIP);   Diagnostic Test: Donor-Derived Cell-Free DNA (dd-cfDNA) Assay;   Drug: Valganciclovir Sponsors:   NYU Langone Health;   Viracor Eurofins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2023 Category: Research Source Type: clinical trials

Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients
Condition:   Kidney Transplant Infection Intervention:   Drug: ROVALCYTE Sponsor:   University Hospital, Rouen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2023 Category: Research Source Type: clinical trials

CMV Immunity Monitoring in Lung Transplant Recipients
Condition:   Lung Transplant; Complications Interventions:   Device: Cytomegalovirus T Cell Immunity Panel (CMV-TCIP);   Diagnostic Test: Donor-Derived Cell-Free DNA (dd-cfDNA) Assay;   Drug: Valganciclovir Sponsors:   NYU Langone Health;   Viracor Eurofins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2023 Category: Research Source Type: clinical trials